Gene therapy in gynecological cancer.

about

Abrogation of estrogen receptor signaling augments cytotoxicity of anticancer drugs on CaSki cervical cancer cells.

P2860

Q35770309-7A33F42C-C610-4F62-BD44-7D53CF5F9B01

P2860

Gene therapy in gynecological cancer.

Item

http://www.wikidata.org/entity/Q36532089

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Gene therapy in gynecological cancer.

@ast

Gene therapy in gynecological cancer.

@en

type

Item

label

Gene therapy in gynecological cancer.

@ast

Gene therapy in gynecological cancer.

@en

prefLabel

Gene therapy in gynecological cancer.

@ast

Gene therapy in gynecological cancer.

@en

P1476

Gene therapy in gynecological cancer.

@en

P2093

David G Mutch

http://www.w3.org/2001/XMLSchema#string

Rebecca A Brooks

http://www.w3.org/2001/XMLSchema#string

P2860

A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase

The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery

Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus

Genetic alterations during colorectal-tumor development

Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells.

Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer.

Human papillomavirus and vulval intra-epithelial neoplasia.

RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo.

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.

Gene therapy for ovarian cancer: progress and potential.

P304

1013-1032

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.6.7.1013

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16831074

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

Gene therapy in gynecological cancer.

about

P2860

P2860

Gene therapy in gynecological cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921